文献速递技术与安全介入CT

碘对比剂短缺:现状与可能机遇——一项系统综述

Shortage of iodinated contrast media: Status and possible chances - A systematic review.
PubMed 文献 · Eur J Radiol · 2023-05-03

该综述检索PubMed与Google Scholar,纳入22篇关于2022年碘对比剂短缺的文章,分析背景、干预措施与低剂量方案的潜在益处。美国与澳大利亚的供应瓶颈催生两类对策:减少增强检查数量与降低单次碘对比剂剂量;两组干预均显著降低碘对比剂使用量,其中减少检查数量对总体用量下降贡献更大。作者认为短缺带来重新审视对比剂增强检查方案的机会,在成本、环境影响与患者安全方面具有潜在优势。

要点

  • 2022年碘对比剂短缺期间,减少增强检查数量对降低总体碘对比剂用量的贡献大于降低单次剂量。
  • 碘对比剂用量减少可提高高危患者安全性,如对比剂过敏反应、对比剂诱导急性肾损伤与甲状腺毒性效应。
  • 作者认为此次短缺是重新审视对比剂增强检查方案与对比剂使用的机会。

核心结论

  • 2022年碘对比剂短缺迫使医疗机构实施节约策略以维持运转,大规模使用低剂量对比剂为未来重新审视对比剂增强检查方案提供了机会。

研究设计与样本

  • 系统综述,检索PubMed与Google Scholar,纳入22篇关于碘对比剂短缺的文章,分析背景、干预措施与低剂量碘对比剂方案的潜在益处。

临床应用与阅片要点

  • 作者认为此次短缺是重新审视对比剂增强检查方案与对比剂使用的机会,在成本、环境影响与患者安全方面具有潜在优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Covid-19 related lockdowns have resulted in a shortage of iodinated contrast media (ICM) in 2022. Health care providers have reacted with implementing conservation strategies to stay operational without compromising patient care. Although articles describing the implemented Interventions have been published, possible chances of the shortage have not yet been mentioned in the literature.

METHODS: We conducted a literature search in PubMed and Google Scholar, and analysed the background, interventions, and possible benefits of low-dose ICM regimens.

RESULTS: We included 22 articles dealing with "ICM shortage" for the analysis. The delivery bottlenecks in the USA and Australia led to two different countermeasures, 1. reduction of the number of contrast-enhanced image-guided examinations and 2. reduction of the (single) ICM dose. Interventions from both groups have resulted in significant reduction of ICM usage; however, group 1 has contributed more to overall ICM reduction. As benefit of the ICM reduction, we revealed an increased safety for patients at risk (e.g. hypersensitivity reactions, contrast-induced acute kidney injury, thyroid toxic effects).

CONCLUSION: The ICM shortage of 2022 has forced health care providers to implement conservation strategies to stay operational. Although there were already proposals for dose reduction before the corona pandemic and the associated supply bottlenecks, this situation led to the use of a reduced amount of contrast agent on a large scale. This presents a good opportunity to reconsider protocols and the use of contrast-enhanced imaging in general for future practice as it offers chances and advantages regarding costs, environmental impact, and patient safety.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Koeppel, Boehm. Shortage of iodinated contrast media: Status and possible chances - A systematic review. Eur J Radiol. 2023. PMID: 37156181. doi:10.1016/j.ejrad.2023.110853

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。